Physician profile
Ari J Benjamin
NPI 1811120934
$5,248.72
in general payments reported to CMS, 2019-2025
25 companies · $693 in 2025
The $693 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $315 · 2021: $262 · 2022: $1,006 · 2023: $813 · 2024: $1,502 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,934 · Education: $73.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,934.34 |
| Education | $73.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,199.52 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $623.11 | 2019-2024 | Bexsero, Arexvy, Shingrix |
| Amgen INC. | $574.74 | 2024-2025 | Repatha, Otezla, Repatha |
| Dexcom, INC. | $443.94 | 2023-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $394.22 | 2022 | |
| Lilly USA, LLC | $305.64 | 2019-2024 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $270.27 | 2020-2024 | Capvaxive, Vaxneuvance, Gardasil |
| Exact Sciences Corporation | $265.84 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $179.42 | 2024 | Breztri, Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $145.17 | 2024-2025 | |
| Global Blood Therapeutics, INC. | $141.39 | 2020-2021 | |
| Viiv Healthcare Company | $124.18 | 2024 | Apretude |
| Gilead Sciences, INC. | $112.74 | 2019-2024 | |
| Renalytix Ai, INC. | $71.52 | 2023-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Abbvie INC. | $66.94 | 2020-2023 | Qulipta |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $66.09 | 2022 | |
| Phadia US INC. | $54.94 | 2019-2024 | Immunocap |
| Pfizer INC. | $45.95 | 2019-2022 | |
| Sanofi Pasteur INC. | $39.34 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $25.85 | 2025 | |
| Vifor Pharma, INC. | $22.75 | 2023 | Veltassa |
| Janssen Pharmaceuticals, INC | $21.86 | 2020 | |
| Philips North America LLC | $19.50 | 2024 | (Ck7) Extended Holter |
| Dynavax Technologies Corporation | $17.20 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.